These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3020314)
21. Effect of sodium intake on the excretion of urinary natriuretic factor in essential hypertensives. Morise T; Miyamori I; Hifumi S; Okamoto S; Ikeda M; Takeda Y; Koshida H; Yasuhara S; Takeda R Endocrinol Jpn; 1985 Jun; 32(3):405-11. PubMed ID: 2995016 [TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography. De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322 [TBL] [Abstract][Full Text] [Related]
23. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis. Asbert M; Clària J; Jiménez W; Arroyo V; Ros J; Gaya J; Rivera F; Rodés J J Hepatol; 1994 May; 20(5):660-5. PubMed ID: 8071545 [TBL] [Abstract][Full Text] [Related]
24. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway. Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798 [TBL] [Abstract][Full Text] [Related]
25. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699 [TBL] [Abstract][Full Text] [Related]
26. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071 [TBL] [Abstract][Full Text] [Related]
27. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade. Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261 [TBL] [Abstract][Full Text] [Related]
28. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension. Masugi F; Ogihara T; Sakaguchi K; Tomii A; Hasegawa T; Chen Y; Azuma M; Kumahara Y J Hypertens Suppl; 1988 Dec; 6(4):S351-3. PubMed ID: 2853743 [TBL] [Abstract][Full Text] [Related]
29. Sensitive assay and kinetic property of urinary inhibitor of Na+, K+-ATPase in sodium-loaded patients with essential hypertension. Masugi F; Ogihara T; Hasegawa T; Imai N; Nagano M; Tabuchi Y; Kumahara Y Jpn Circ J; 1985 Sep; 49(9):980-3. PubMed ID: 2999460 [TBL] [Abstract][Full Text] [Related]
30. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension. Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421 [TBL] [Abstract][Full Text] [Related]
31. Na+,K+-ATPase interaction with a brain endogenous inhibitor (endobain E). Rodríguez de Lores Arnaiz G; Reinés A; Herbin T; Peña C Neurochem Int; 1998 Nov; 33(5):425-33. PubMed ID: 9874093 [TBL] [Abstract][Full Text] [Related]
32. Relation of endogenous digoxin-like immunoreacting activities to salt balance and renal function in man. Kramer HJ; Heppe M; Pennig J; Kipnowski J; Klingmüller D; Düsing R; Krück F Klin Wochenschr; 1985; 63 Suppl 3():107-10. PubMed ID: 2987606 [TBL] [Abstract][Full Text] [Related]
33. Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor. Bersier MG; Miksztowicz V; Peña C; Rodríguez de Lores Arnaiz G Neurochem Res; 2005 Apr; 30(4):479-86. PubMed ID: 16076019 [TBL] [Abstract][Full Text] [Related]
34. Effects of human urine-derived digitalis-like factor on cultured renal tubular epithelial cells. Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T J Hypertens Suppl; 1988 Dec; 6(4):S287-9. PubMed ID: 2853736 [TBL] [Abstract][Full Text] [Related]
35. Purification of endogenous digitalis-like factors from normal human urine. Goto A; Yamada K Clin Exp Hypertens; 1998; 20(5-6):551-6. PubMed ID: 9682911 [TBL] [Abstract][Full Text] [Related]
36. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides. Chiou S; Vesely DL Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651 [TBL] [Abstract][Full Text] [Related]
37. Measurement of endogenous Na+,K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography. Crabos M; Wainer IW; Cloix JF FEBS Lett; 1984 Oct; 176(1):223-8. PubMed ID: 6208054 [TBL] [Abstract][Full Text] [Related]
38. [Purification of an endogenous inhibitor of sodium-potassium-ATPase]. Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528 [TBL] [Abstract][Full Text] [Related]
39. Vanadium-diascorbates are strong candidates for endogenous ouabain-like factors in human urine: effects on Na-K-ATPase enzyme kinetics. Kramer HJ; Krampitz G; Bäcker A; Krampitz G; Meyer-Lehnert H Biochem Biophys Res Commun; 1995 Aug; 213(1):289-94. PubMed ID: 7639747 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of guinea-pig renal [Na + K]-ATPase by normotensive human plasma: effects of a high sodium diet. Wellard RM; Myers JB; Danks JA; Morgan TO; Adam WR Clin Exp Pharmacol Physiol; 1983; 10(3):261-4. PubMed ID: 6313263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]